Thinq Pharma-CRO Pte. Ltd.

Quick facts

Phase 3 pipeline

• Roxane Laboratories Inc., USA · Attention deficit hyperactivity disorder
  Roxane Laboratories Inc., USA's drug is a central nervous system stimulant.
• Unique Pharmaceutical Laboratories, India
  Unique Pharmaceutical Laboratories' drug is a small molecule in phase 3 clinical trials.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Thinq Pharma-CRO Pte. Ltd. portfolio CI brief
• Thinq Pharma-CRO Pte. Ltd. pipeline updates RSS